BSEVivo Bio Tech LtdLowNeutral
Announced Tue, 26 Aug · 15:49 IST

Please find enclosed outcome of the Board Meeting

Management Changes View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

The board approved convening the 38th Annual General Meeting on September 30, 2025, to be held via video conferencing. The Board’s Report for the financial year ended March 31, 2025 was also approved. Dr. Sankaranarayanan Alangudi (DIN: 02703392), who retires by rotation, was re-appointed as a director, subject to shareholder approval. The board also approved the appointment of Mr. Vinay Babu Gade, a Company Secretary in Practice from Hyderabad, as the Secretarial Auditor for five consecutive years from FY 2025-26 to FY 2029-30, pending shareholder approval at the AGM.

Likely market impact

These are routine governance and compliance decisions with no material impact on the stock. The new secretarial auditor appointment is a regulatory requirement under amended SEBI Listing Regulations, and the director re-appointment is standard rotation practice.